NCT06491043View on ClinicalTrials.gov

Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 11, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2027

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
OTHER

UMC119-06-05

Human Umbilical Cord Derived-Mesenchymal Stem Cells

Trial Locations (2)

333

RECRUITING

Chang Gung Memorial Hospital, Linkou, Taoyuan

23561

RECRUITING

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare, New Taipei City

All Listed Sponsors
lead

Meribank Biotech Co., Ltd.

INDUSTRY